Validation of clinical and epidemiological diagnosis criterion for confirming cholera

OBJECTIVE: To validate the clinical and epidemiological diagnosis criterion for confirming cholera suspect cases. METHODS: The study comprised 2,687 and 716 patients admitted with diarrhea to a public hospital in Maceió, Brazil, in 1992 and 1997 respectively. Culture of V. cholerae O1 (Koch, 1884) in TCBS-agar was performed and the clinical and epidemiological criterion was applied and compared to the gold standard. The statistical analysis was carried out in two age-groups: less than five years old and five years old or more. RESULTS: There were studied 833 patients, of which 517 in 1992 and 316 in 1997; 72 aged less than five years and 761 aged five years or more. In those aged less than five years in 1992, sensitivity was 40% and specificity 84.6%. For this same age-group in 1997, sensitivity was 28.6% and specificity 62.5%. In patients aged five years or more in 1992, sensitivity was 99% and specificity 1.2%. For this same age-group in 1997, sensitivity was 86.9% and specificity 8.7%. CONCLUSION: The higher sensitivity of the clinical and epidemiological cholera diagnosis criterion in patients aged five years or more found in the study support its application during epidemics periods. In periods of lower incidence, all cases need to be confirmed using laboratory methods.OBJETIVO: Validar o critério diagnóstico clínico-epidemiológico para confirmação de casos suspeitos da cólera. MÉTODOS: Foram estudados pacientes em um hospital público em Maceió, sendo 2.687 do ano de 1992 e 716 de 1997. Nos pacientes admitidos com diarréia, que realizaram pesquisa do Vibrio cholerae O1 (Koch, 1884) pelo cultivo em TCBS-agar, foi aplicado o critério clínico-epidemiológico comparando-o com o padrão-ouro. A análise foi feita por faixa etária - menor que cinco anos e igual ou maior a cinco anos - em 1992 e 1997. RESULTADOS: Foram estudados 833 pacientes, 517 em 1992 e 316 em 1997; 72 com idade menor que cinco anos e 761 com idade igual ou maior a cinco anos. Nos pacientes menores que cinco anos, em 1992, a sensibilidade foi de 40%, enquanto a especificidade foi de 84,6%. Para a mesma faixa etária, em 1997, a sensibilidade foi de 28,6%. Já a especificidade foi de 62,5%. Nos pacientes com idade igual ou superior a cinco anos, em 1992, a sensibilidade e a especificidade foram de 99% e 1,2%; respectivamente. Para a mesma faixa etária, em 1997, a sensibilidade foi de 86,9%, enquanto a especificidade foi de 8,7%. CONCLUSÃO: A elevada sensibilidade do critério diagnóstico clínico-epidemiológico da cólera nos pacientes com idade igual ou maior que cinco anos, nos dois anos estudados, recomenda sua aplicação nos períodos de epidemia. Quando a incidência baixa, todos os casos devem ter confirmação laboratorial

Avaliação do teste imunocromatográfico ("ICT card test") no diagnóstico da filariose em estudos populacionais

This study evaluated the whole blood immunochromatographic card test (ICT card test) in a survey performed in Northeastern Brazil. 625 people were examined by the thick blood film (TBF) and ICT card test. Residents of a non-endemic area were also tested by the whole blood card test and Og4C3. The sensitivity of the ICT card test was 94.7% overall, but lower in females than males, based on the reasonable assumption that TBF is 100% specific. However, since TBF and other methods have unknown sensitivity, the true specificity of the card test is unknown. Nevertheless, it is possible to estimate upper and lower limits for the specificity, and relate it to the prevalence of the disease. In the endemic area, the possible range of the specificity was from 72.4% to 100%. 29.6% of the card tests performed in the non-endemic area exhibited faint lines that were interpreted as positives. Characteristics of the method including high sensitivity, promptness and simplicity justify its use for screening of filariasis. However, detailed information about the correct interpretation in case of extremely faint lines is essential. Further studies designed to consider problems arising from imperfect standards are necessary, as is a sounder diagnostic definition for the card test.Este estudo avaliou o teste imunocromatográfico ("ICT card test") em inquérito de filariose realizado no município de Olinda, Brasil. 625 pessoas foram examinadas pela técnica da gota espessa (GE), e "ICT card test" (ICT). Moradores do município de Campina Grande, Paraíba, área não endêmica, foram examinados pelos testes ICT e Og4C3-ELISA, para verificação da especificidade. A sensibilidade do método foi de 94,7%. O desenho do estudo - que envolveu a acurácia do ICT e do teste de referência (GE), em todos os elementos da amostra, - e a especificidade de 100% da GE permitiram o cálculo correto da sensibilidade. Todavia, como a sensibilidade da GE é desconhecida, a especificidade do ICT é ignorada. É possível, contudo, estimar o limite superior e inferior da especificidade e relacioná-la à prevalência de doença. Na área endêmica, a especificidade do teste variou entre 72,4% e 100,0%. 29,6% dos exames pelo ICT, realizados na área não endêmica, exibiram coloração tênue, tendo sido interpretados como positivos. Algumas características do método, incluindo alta sensibilidade, rapidez e simplicidade de execução justificam sua utilização em rastreamento de áreas endêmicas. Todavia, detalhes acerca da correta interpretação dos resultados com coloração extremamente tênue, parecem de importância fundamental

The legacy of ZikaPLAN: a transnational research consortium addressing Zika

Global health research partnerships with institutions from high-income countries and low- and middle-income countries are one of the European Commission's flagship programmes. Here, we report on the ZikaPLAN research consortium funded by the European Commission with the primary goal of addressing the urgent knowledge gaps related to the Zika epidemic and the secondary goal of building up research capacity and establishing a Latin American-European research network for emerging vector-borne diseases. Five years of collaborative research effort have led to a better understanding of the full clinical spectrum of congenital Zika syndrome in children and the neurological complications of Zika virus infections in adults and helped explore the origins and trajectory of Zika virus transmission. Individual-level data from ZikaPLAN`s cohort studies were shared for joint analyses as part of the Zika Brazilian Cohorts Consortium, the European Commission-funded Zika Cohorts Vertical Transmission Study Group, and the World Health Organization-led Zika Virus Individual Participant Data Consortium. Furthermore, the legacy of ZikaPLAN includes new tools for birth defect surveillance and a Latin American birth defect surveillance network, an enhanced Guillain-Barre Syndrome research collaboration, a de-centralized evaluation platform for diagnostic assays, a global vector control hub, and the REDe network with freely available training resources to enhance global research capacity in vector-borne diseases

Risk-factors for non-adherence to antiretroviral therapy

Cross-sectional study analyzed as case-control to identify risk factors for non-adherence to antiretroviral therapy. We studied 412 out-clinics HIV infected subjects of three public hospitals of Recife, Pernambuco. The objective was to examine the association between non-adherence to the antiretroviral therapy and biological, social-behavior and demographics and economic factors, factors related to the disease and/or treatment, factors related to life habits and depression symptoms. Variables significantly associated with non-adherence to antiretroviral therapy were: time elapsed since HIV diagnosis (p = 0.002), daily dose (p = 0.046), use of alcohol (p = 0.030) and past drug use (p = 0.048), and borderline p-values were found for educational level (p = 0.093) and family monthly income (p = 0.08). In the multivariable analysis, the factors that remained in the final model were family monthly income, time period with HIV infection and use of alcohol. No association was observed between non-adherence to antiretroviral therapy and gender, age, sexual orientation, marital status, educational level and place of residence. Based on our results and the local situation we suggest: assessment of social needs; training of partners and/or families on supporting adherence, creation of "adherence groups" to motivate and to reassure patients on the benefits of treatment; counseling and/or psychotherapy for alcohol drinkers

ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas.

Zika Preparedness Latin American Network (ZikaPLAN) is a research consortium funded by the European Commission to address the research gaps in combating Zika and to establish a sustainable network with research capacity building in the Americas. Here we present a report on ZikaPLAN`s mid-term achievements since its initiation in October 2016 to June 2019, illustrating the research objectives of the 15 work packages ranging from virology, diagnostics, entomology and vector control, modelling to clinical cohort studies in pregnant women and neonates, as well as studies on the neurological complications of Zika infections in adolescents and adults. For example, the Neuroviruses Emerging in the Americas Study (NEAS) has set up more than 10 clinical sites in Colombia. Through the Butantan Phase 3 dengue vaccine trial, we have access to samples of 17,000 subjects in 14 different geographic locations in Brazil. To address the lack of access to clinical samples for diagnostic evaluation, ZikaPLAN set up a network of quality sites with access to well-characterized clinical specimens and capacity for independent evaluations. The International Committee for Congenital Anomaly Surveillance Tools was formed with global representation from regional networks conducting birth defects surveillance. We have collated a comprehensive inventory of resources and tools for birth defects surveillance, and developed an App for low resource regions facilitating the coding and description of all major externally visible congenital anomalies including congenital Zika syndrome. Research Capacity Network (REDe) is a shared and open resource centre where researchers and health workers can access tools, resources and support, enabling better and more research in the region. Addressing the gap in research capacity in LMICs is pivotal in ensuring broad-based systems to be prepared for the next outbreak. Our shared and open research space through REDe will be used to maximize the transfer of research into practice by summarizing the research output and by hosting the tools, resources, guidance and recommendations generated by these studies. Leveraging on the research from this consortium, we are working towards a research preparedness network

Zika virus infection in pregnancy: a protocol for the joint analysis of the prospective cohort studies of the ZIKAlliance, ZikaPLAN and ZIKAction consortia

INTRODUCTION: Zika virus (ZIKV) infection in pregnancy has been associated with microcephaly and severe neurological damage to the fetus. Our aim is to document the risks of adverse pregnancy and birth outcomes and the prevalence of laboratory markers of congenital infection in deliveries to women experiencing ZIKV infection during pregnancy, using data from European Commission-funded prospective cohort studies in 20 centres in 11 countries across Latin America and the Caribbean. METHODS AND ANALYSIS: We will carry out a centre-by-centre analysis of the risks of adverse pregnancy and birth outcomes, comparing women with confirmed and suspected ZIKV infection in pregnancy to those with no evidence of infection in pregnancy. We will document the proportion of deliveries in which laboratory markers of congenital infection were present. Finally, we will investigate the associations of trimester of maternal infection in pregnancy, presence or absence of maternal symptoms of acute ZIKV infection and previous flavivirus infections with adverse outcomes and with markers of congenital infection. Centre-specific estimates will be pooled using a two-stage approach. ETHICS AND DISSEMINATION: Ethical approval was obtained at each centre. Findings will be presented at international conferences and published in peer-reviewed open access journals and discussed with local public health officials and representatives of the national Ministries of Health, Pan American Health Organization and WHO involved with ZIKV prevention and control activities

Validação do critério diagnóstico clínico-epidemiológico para confirmação da cólera

OBJETIVO: Validar o critério diagnóstico clínico-epidemiológico para confirmação de casos suspeitos da cólera. MÉTODOS: Foram estudados pacientes em um hospital público em Maceió, sendo 2.687 do ano de 1992 e 716 de 1997. Nos pacientes admitidos com diarréia, que realizaram pesquisa do Vibrio cholerae O1 (Koch, 1884) pelo cultivo em TCBS-agar, foi aplicado o critério clínico-epidemiológico comparando-o com o padrão-ouro. A análise foi feita por faixa etária - menor que cinco anos e igual ou maior a cinco anos - em 1992 e 1997. RESULTADOS: Foram estudados 833 pacientes, 517 em 1992 e 316 em 1997; 72 com idade menor que cinco anos e 761 com idade igual ou maior a cinco anos. Nos pacientes menores que cinco anos, em 1992, a sensibilidade foi de 40%, enquanto a especificidade foi de 84,6%. Para a mesma faixa etária, em 1997, a sensibilidade foi de 28,6%. Já a especificidade foi de 62,5%. Nos pacientes com idade igual ou superior a cinco anos, em 1992, a sensibilidade e a especificidade foram de 99% e 1,2%; respectivamente. Para a mesma faixa etária, em 1997, a sensibilidade foi de 86,9%, enquanto a especificidade foi de 8,7%. CONCLUSÃO: A elevada sensibilidade do critério diagnóstico clínico-epidemiológico da cólera nos pacientes com idade igual ou maior que cinco anos, nos dois anos estudados, recomenda sua aplicação nos períodos de epidemia. Quando a incidência baixa, todos os casos devem ter confirmação laboratorial